Nuclear Medicine Market - Top Companies and Manufacturers

  • Report ID: 4456
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Nuclear Medicine Landscape

    • GE Healthcare
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Jubilant Pharmova Limited
    • Nordion (Canada), Inc.
    • Bracco Imaging S.P.A
    • The Institute for Radioelements (IRE)
    • NTP Radioisotopes SOC Ltd.
    • The Australian Nuclear Science and Technology Organization (ANSTO)
    • Mallinckrodt Pharmaceuticals
    • Lantheus
    • Eckert & Ziegler

Browse Key Market Insights with Data Illustration:

In the News

  • A new generation nuclear medicine scanner for use in cardiac imaging has been unveiled by GE Healthcare. It has an expanded field-of-view processing capability and new automated workflow features for a quick, comfortable exam. MyoSPECT provides a remarkable picture of cardiac architecture and pathology to aid doctors in choosing the best course of treatment for patients. It was developed using the company's proprietary Alcyone technology and CZT module design.

  • The Institute for Radioelements (IRE), a pioneer in the manufacturing of Molybdenum-99 (Mo-99), the radioisotope that is most frequently used in nuclear medicine for diagnostics, announced that it has produced its first batch of Mo-99 Low Enriched Uranium (LEU) for the US market.


Author Credits:  Radhika Pawar


  • Report ID: 4456
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of nuclear medicine is estimated at USD 15.04 billion.

The nuclear medicine market size was over USD 12.94 billion in 2024 and is set to cross USD 143.71 billion by the end of 2037, growing at more than 20.1% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by growing prevalence of cardiovascular diseases, growing geriatric population, new product launches by key players, and others.

Asia Pacific industry is poised to dominate majority revenue share by 2037, owing to increasing awareness about nuclear medicine and growing investment in nuclear medicine space in the region.

The major players in the market include GE Healthcare, Jubilant Pharmova Limited, Nordion (Canada), Inc., Bracco Imaging S.P.A, The Institute for Radioelements (IRE), NTP Radioisotopes SOC Ltd., The Australian Nuclear Science and Technology Organization (ANSTO), Mallinckrodt Pharmaceuticals, Lantheus, Eckert & Ziegler.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample